Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Charlottesville biotech support helps startups like Luminoah and Rivus grow, with the Manning Institute and CvilleBioHub leading the way ...

Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Synthego, a Redwood City biotech company that raised millions but saw its debt costs become insurmountable, declared ...

Stellenbosch University’s (SU’s) new incubator dedicated to biotech startups, LaunchLab CERIBio, was full even before its’ ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

ReproNovo has licensed rights to two drugs from Mereo BioPharma and ObsEva that it thinks could address fertility issues in ...